New SGEI de minimis Regulation sets clear threshold for exemptions from state aid rules
The European Commission has adopted the last pillar of a new package of state aid rules for SGEI. The most recent Regulation exempts certain compensation for the provision of services of general economic interest (SGEI) from state aid rules. If the SGEI compensation was granted at € 500,000 per company, over a three-year period, then it does not constitute state aid. The Regulation will be in effect until December 31, 2018.
The European Commission determined that such compensation is “unproblematic because it is too low to have any impact on trade and competition.” Vice President of the Commission for competition policy, Joaquín Almunia, noted that the Regulation will help facilitate the provision of public services, as well as allow the Commission to prioritize and focus on those state aid cases that significantly affect competition.
Moreover, the SGEI de minimis Commission Regulation increases legal certainty with its clear € 500,000 threshold. Administrative burdens are also allayed with the elimination of previous conditions that needed to be calculated, such as the provider’s turnover and the size of the local authority granting the aid.
Full content: EC Press Release
Related content: Identifying, Challenging, and Assigning Political Responsibility for State Regulation Restricting Competition (Maureen Ohlhausen, Federal Trade Commission)
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas